{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:56:44Z","timestamp":1768265804797,"version":"3.49.0"},"reference-count":14,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:00:00Z","timestamp":1613865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomography found abnormalities classified as possible diffuse COVID-19 pneumonia. RT-PCR for Sars-Cov-2 was twice negative. PCR for Pneumocystis jirovecii was positive on bronchoalveolar lavage. The final diagnosis was Pneumocystis jirovecii pneumonia. Therefore, physicians must be careful not to misdiagnose COVID-19, especially in cancer patients on small-molecule therapeutics like gefitinib and corticosteroids.<\/jats:p>","DOI":"10.3390\/curroncol28010094","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T22:04:15Z","timestamp":1613945055000},"page":"961-964","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Not COVID-19, Don\u2019t Overlook Pneumocystis in Patients on Gefitinib!"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7140-8415","authenticated-orcid":false,"given":"J\u00e9r\u00e9my","family":"Barben","sequence":"first","affiliation":[{"name":"Geriatrics Department, University Hospital of Dijon, 21000 Dijon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Quipourt","sequence":"additional","affiliation":[{"name":"Geriatrics Department, University Hospital of Dijon, 21000 Dijon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9mie","family":"Vovelle","sequence":"additional","affiliation":[{"name":"Geriatrics Department, University Hospital of Dijon, 21000 Dijon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-554X","authenticated-orcid":false,"given":"Alain","family":"Putot","sequence":"additional","affiliation":[{"name":"Geriatrics Department, University Hospital of Dijon, 21000 Dijon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5518-9803","authenticated-orcid":false,"given":"Patrick","family":"Manckoundia","sequence":"additional","affiliation":[{"name":"Geriatrics Department, University Hospital of Dijon, 21000 Dijon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1007\/s00330-020-06801-0","article-title":"Chest CT Manifestations of New Coronavirus Disease 2019 (COVID-19): A Pictorial Review","volume":"30","author":"Ye","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, A., Pal\u00e1sti, P., Ver\u00e9b, D., Bozsik, B., Palk\u00f3, A., and Kincses, Z.T. (2020). The Sensitivity and Specificity of Chest CT in the Diagnosis of COVID-19. Eur. Radiol.","DOI":"10.1007\/s00330-020-07347-x"},{"key":"ref_3","unstructured":"The RECOVERY Collaborative Group (2020). Dexamethasone in Hospitalized Patients with Covid-19\u2014Preliminary Report. N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/RTI.0000000000000524","article-title":"Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA\u2014Secondary Publication","volume":"35","author":"Simpson","year":"2020","journal-title":"J. Thorac. Imaging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3348\/kjr.2019.0057","article-title":"A Stepwise Diagnostic Approach to Cystic Lung Diseases for Radiologists","volume":"20","author":"Lee","year":"2019","journal-title":"Korean J Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000487713","article-title":"Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis Jirovecii Pneumonia","volume":"96","author":"Salzer","year":"2018","journal-title":"Respiration"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.cmi.2018.02.009","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the Safety of Targeted and Biological Therapies: An Infectious Diseases Perspective (Intracellular Signaling Pathways: Tyrosine Kinase and MTOR Inhibitors)","volume":"24","author":"Reinwald","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.cllc.2018.12.006","article-title":"Immunosuppression for Immune Checkpoint-Related Toxicity Can Cause Pneumocystis Jirovecii Pneumonia (PJP) in Non\u2013Small-Cell Lung Cancer (NSCLC): A Report of 2 Cases","volume":"20","author":"Schwarz","year":"2019","journal-title":"Clin. Lung Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/sjmms.sjmms_255_18","article-title":"Pneumocystis Jirovecii Pneumonia in a Non-Small Cell Lung Cancer Patient on Chemoradiotherapy: A Case Report","volume":"8","author":"Doello","year":"2020","journal-title":"Saudi J. Med. Med. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cid\/cix687","article-title":"Call for Action: Invasive Fungal Infections Associated with Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways","volume":"66","author":"Chamilos","year":"2018","journal-title":"Clin. Infect Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00281-018-0697-6","article-title":"Does Patient Age Influence Anti-Cancer Immunity?","volume":"41","author":"Pawelec","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/bloodadvances.2020001678","article-title":"Pneumocystis Jirovecii Pneumonia and Institutional Prophylaxis Practices in CLL Patients Treated with BTK Inhibitors","volume":"4","author":"Ryan","year":"2020","journal-title":"Blood Adv."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/s41598-019-38618-3","article-title":"Risk Factors and Clinical Characteristics of Pneumocystis Jirovecii Pneumonia in Lung Cancer","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-3-319-91442-8_16","article-title":"Gefitinib","volume":"211","author":"Rawluk","year":"2018","journal-title":"Recent Results Cancer Res."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/1\/94\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:27:16Z","timestamp":1760160436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/1\/94"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,21]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["curroncol28010094"],"URL":"https:\/\/doi.org\/10.3390\/curroncol28010094","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,21]]}}}